Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 136

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 136
---
 receivables, amount due from shareholders and loan to A SPAC I

NewGenIvf assessed the impairment
for deposits and other receivables, due from shareholders and loan to A SPAC I individually based on internal credit rating and ageing
of these debtors which, in the opinion of the directors, have no significant increase in credit risk since initial recognition. Based
on the impairment assessment performed by the Company, the directors consider the loss allowance for deposits and other receivables and
due from shareholders as of December 31, 2024 was US$4 and Nil respectively. The loss allowance for deposits and other receivables, and
due from shareholders and loan to A SPAC I as of December 31, 2023 is $14, $17,818 and Nil, respectively.

Cash flow interest rate risk

NewGenIvf is exposed to cash
flow interest rate risk through the changes in interest rates related mainly to its variable-rates bank balances.

NewGenIvf currently does not
have any interest rate hedging policy in relation to fair value interest rate risk and cash flow interest rate risk. The directors monitor
NewGenIvf’s exposures on an ongoing basis and will consider hedging the interest rate should the need arises.

Sensitivity analysis

The sensitivity analysis below
has been determined by assuming that a change in interest rates had occurred at the end of the reporting period and had been applied to
the exposure to interest rates for financial instruments in existence at that date. 1% increase or decrease is used when reporting interest
rate risk internally to key management personnel and represents management’s assessment of the reasonably possible change in interest
rates.

If interest rates had been
1% higher or lower and all other variables were held constant, NewGenIvf’s post tax loss for the years ended December 31,
2024 and 2023 would have increased or decreased by approximately US$26,894 and US$122, respectively.

Foreign currency risk

Foreign currency risk is the
risk that the holding of foreign currency assets will affect NewGenIvf’s financial position as a result of a change in foreign currency
exchange rates.

NewGenIvf’s monetary
assets and liabilities are mainly denominated in HK$ and THB which are the same as the functional currencies of the relevant group entities.
Hence, in the opinion of the directors of NewGenIvf, the currency risk of US$ is considered insignificant. NewGenIvf currently does not
have a foreign currency